Barbra Hanna, DO
Obstetrics & Gynecology · Wheaton, ILNPI 1235322090
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,235 of the $7,027 with a category attached, or 88.7%. Astellas Pharma US Inc accounts for 72.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $4,304 and has fallen 55.9% since, to $1,897 in 2025. Among obstetrics & gynecology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 21 payments — averaging $334.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$5K
- Bayer$2K
- Lilly USA, LLC$64
- Exact Sciences$44
- Novo Nordisk$29
- Ascend Therapeutics US, LLC$20
- plus $36 from 2 others
What the payments were for
- Speaking & faculty fees$6,23589%
- Food & beverage$79211%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 9 | $5,121 |
| Bayer | 2 | $1,714 |
| Lilly USA, LLC | 3 | $64 |
| Exact Sciences | 2 | $44 |
| Novo Nordisk | 2 | $29 |
| Ascend Therapeutics US, LLC | 1 | $20 |
| Astellas Pharma Global Development | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,027 in reported general payments places this provider in the 90th percentile of 1,732 obstetrics & gynecology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 80 | $4,765 |
| Estradiol (Twice Weekly)Estradiol | 17 | $1,778 |
| ProgesteroneProgesterone, Micronized | 24 | $1,074 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Wheaton
- Katherine HyonWheaton$15K
- Lee ShulmanChicago$559K
- Anne SchaibleOak Lawn$546K
- Christopher OlsonNaperville$530K
- Maria TamChicago$378K
- Charles MillerNaperville$317K
- Gregory UrsinoChicago$242K
- Buthaina JabirNaperville$199K
- Frank TugwellSterling$140K
- Ayman Al-HendyChicago$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.